Page last updated: 2024-08-24

plerixafor and Carcinoma, Lewis Lung

plerixafor has been researched along with Carcinoma, Lewis Lung in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, X; Farber, JM; Jacobson, O; Jacobus, JP; Kiesewetter, DO; Szajek, LP; Weiss, ID1
Benayoun, L; Bril, R; Gingis-Velitski, S; Kerbel, RS; Man, S; Milsom, C; Munster, M; Shaked, Y; Voloshin, T1

Other Studies

2 other study(ies) available for plerixafor and Carcinoma, Lewis Lung

ArticleYear
Positron emission tomography imaging of tumors expressing the human chemokine receptor CXCR4 in mice with the use of 64Cu-AMD3100.
    Molecular imaging and biology, 2012, Volume: 14, Issue:1

    Topics: Animals; Benzylamines; Carcinoma, Lewis Lung; Cell Line, Tumor; CHO Cells; Copper Radioisotopes; Cricetinae; Cricetulus; Cyclams; Female; Heterocyclic Compounds; Humans; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C57BL; Molecular Imaging; Neoplasms, Experimental; Ovarian Neoplasms; Positron-Emission Tomography; Radiation Dosage; Radiopharmaceuticals; Receptors, CXCR4; Tissue Distribution; Transfection; Transplantation, Heterologous

2012
G-CSF supplementation with chemotherapy can promote revascularization and subsequent tumor regrowth: prevention by a CXCR4 antagonist.
    Blood, 2011, Sep-22, Volume: 118, Issue:12

    Topics: Animals; Antineoplastic Agents; Benzylamines; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclams; Drug Combinations; Female; Flow Cytometry; Granulocyte Colony-Stimulating Factor; Heterocyclic Compounds; Humans; Immunohistochemistry; Inflammatory Breast Neoplasms; Injections, Intraperitoneal; Matrix Metalloproteinase 2; Mice; Mice, Knockout; Neovascularization, Pathologic; Paclitaxel; Receptors, CXCR4; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2011